12-49033581-G-C
Variant summary
The NM_003482.4(KMT2D):c.11124C>G (p.Ser3708Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene KMT2D is a tumor suppressor gene (CancerMine: 29 TSG, 29 oncogene, 10 driver citations). The gene KMT2D is a known oncogene (CancerMine: 29 TSG, 29 oncogene, 10 driver citations). The gene KMT2D is a cancer driver gene (CancerMine: 29 TSG, 29 oncogene, 10 driver citations). The variant allele was found at a cumulative frequency of 0.0000186 (AC=30) in the gnomAD database across 1,613,444 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000416. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (no review stars). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.S3708G: Likely_benign (ClinVar VariationId 2730835, 1 star); p.S3708N: Likely_benign (ClinVar VariationId 2789703, 1 star); p.S3708= (synonymous): Benign (ClinVar VariationId 3603375, 1 star) The variant has been observed in cBioPortal in 2 samples across 1 study and 1 cancer type; somatic enrichment level: SUPPORTING_LOW (Observed in a small number of cBioPortal cases.).
Frequency
Consequence
NM_003482.4 missense
Scores
Clinical Significance
Conservation
Publications
- choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Illumina, PanelApp Australia
- Kabuki syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine, ClinGen
- branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Kabuki syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 0 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
No applied criteria Uncheck "Show applied only" above to review all 20 criteria. | |||
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_003482.4. You can select a different transcript below to see updated classification assignments.
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
KMT2D | TSL:5MANE Select | c.11124C>G p.Ser3708Arg | missense | Exon 40 of 55 | Prot: ENSP00000301067.7 UniProt: | |
KMT2D | c.11124C>G p.Ser3708Arg | missense | Exon 40 of 56 | Prot: ENSP00000506726.1 UniProt: | ||
KMT2D | c.11133C>G p.Ser3711Arg | missense | Exon 39 of 54 | Prot: ENSP00000509386.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.0000329 | AC:5 | Hom:0 | AN:152140 | Cov:33 |
GnomAD2 exomes | AF: 0.000109 | AC:27 | AN:248538 | ||
GnomAD4 exome | AF: 0.0000171 | AC:25 | Hom:0 | AN:1461304 | Cov:45 |
GnomAD4 genome | AF: 0.0000329 | AC:5 | Hom:0 | AN:152140 | Cov:33 |
TOPMed (Bravo) | AF: 0.0000113 | AC:3 | Hom:0 | AN:264690 | |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.0000387 | AC:1 | Hom:0 | AN:25826 | |
Local & regional cohorts 3 sources | |||||
ChinaMAP Phase 1 | AF: 0.00108 | ||||
ToMMo 61KJPN (+60KJPN MNV) | AF: 0.00000800 | AC:1 | Hom:0 | AN:122168 | |
WBBC (Westlake BioBank for Chinese) pilot | AF: 0.000446 | AC:4 | Hom:0 | AN:8960 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
Epi25 | 0.0000715 | 3 | 41958 | 0.0000897 | 6 | 66888 |
SCHEMA | 0.000307 | 31 | 101002 | 0.000138 | 25 | 181600 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 25 | |
AlphaMissense | Pathogenic | 0.89 | |
BayesDel_addAF | Benign | -0.40 | T |
BayesDel_noAF | Benign | -0.35 | |
CADD | Benign | 20 | |
DANN | Benign | 0.92 | |
DEOGEN2 | Benign | 0.047 | T |
Eigen | Benign | -0.32 | |
Eigen_PC | Benign | -0.13 | |
FATHMM_MKL | Uncertain | 0.79 | D |
FuncVEP CTI | Benign | 0.0017 | |
GPN-Star LLR | N/A | -7.9 | |
GPN-Star score | N/A | 7.9 | |
LIST_S2 | Benign | 0.69 | T |
M_CAP | Pathogenic | 0.37 | D |
MetaRNN | Benign | 0.034 | T |
MetaSVM | Benign | -0.64 | T |
Mutation Taster | N/A | 78/22 | polymorphism |
MutationAssessor | Benign | 0.34 | N |
PhyloP100 | Benign | 1.3 | |
PrimateAI | Benign | 0.47 | T |
PROVEAN | Benign | -1.1 | N |
REVEL | Uncertain | 0.37 | |
Sift | Benign | 0.042 | D |
Varity_R | N/A | 0.091 | |
VESM-3B | Benign | -6.5 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.010 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.